O-antigen targeted vaccines against E. coli may be useful in reducing morbidity, mortality and antimicrobial resistance.
Guilhem RoyerOlivier ClermontBénédicte CondamineMélanie Mercier-DartyCédric LaouénanAgnès LefortErick DenamurVictoire de Lastoursnull nullPublished in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2021)